Friday 6-6-2014 Pfizer Inc (PFE) $PFE opened at 29.81 hitting the high price of 29.87 and a day low of 29.34 with a total volume of 26,817,000. PFE had a previous close of 29.76 and has been seeing an average volume of 26,137,785.
Overall Average: 56% Sell
Recent stock forum discussions about PFE http://investorshangout.com/search?q=PFE&...mp;yt0=Go!
As Dividend Stocks Go, Philip Morris Is Expensive: Here Is a Cheaper Pick
Rupert Hargreaves, The Motley Fool - Motley Fool - Sat Jun 07, 9:00AM CDT
Every portfolio should have a dividend stock at its core to provide a degree of diversification and stability. The best dividend stocks are usually found within the consumer goods sector as the sector's defensive nature means that cash flows are... (full story)
Most active New York Stock Exchange-traded stocks
AP - Fri Jun 06, 5:13PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading: (full story)
Final Glance: Pharmaceuticals companies
AP - Fri Jun 06, 5:13PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading: (full story)
Pfizer Set to Possibly Rebound After Yesterday's Selloff of 1.14%
Comtex SmarTrend(R) - Fri Jun 06, 4:20PM CDT
Pfizer (NYSE
FE) traded in a range yesterday that spanned from a low of $29.34 to a high of $29.87. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $29.48 on volume of 26.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. (full story)
The Dow Sets Another Record, But Why Are Pharma Stocks Falling?
Dan Caplinger, The Motley Fool - Motley Fool - Fri Jun 06, 3:30PM CDT
The Dow Jones Industrials set another all-time high on Friday, rising nearly 88 points and marking the eighth time the index has hit unprecedented levels this year. The catalyst for today's spike was the May employment report from the Labor... (full story)
Pfizer Falls, but the Dow's Record Run Continues
Dan Carroll, The Motley Fool - Motley Fool - Fri Jun 06, 1:38PM CDT
Stocks this afternoon as continuing the record run that has the Dow Jones Industrial Average touching a series of new highs. As of 2:30 p.m. EDT, the Dow had gained more than 78 points and sat just 85 points shy of the 17,000 mark. Most... (full story)
Midday Glance: Pharmaceuticals companies
AP - Fri Jun 06, 12:22PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.: (full story)
Early Glance: Pharmaceuticals companies
AP - Fri Jun 06, 10:46AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.: (full story)
5 Toxic Big Pharma Stocks You Need to Sell This Summer
at The Street - Fri Jun 06, 10:33AM CDT
As the summer fast approaches, pharma and medical device stocks are starting to show some nasty side effects. (full story)
Genomic Health Up on Fresh Cancer Study Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 05, 1:50PM CDT
Genomic Health's (GHDX) shares were up around 3.4% in the trading session following the news release. (full story)
Lannett Tops Trio Of Medical Small Cap Leaders
at Investor's Business Daily - Thu Jun 05, 7:02AM CDT
Small, fast-growing companies in hot industries, such as generics drugmaker Lannett, are good prospects for a stock watch list. Today's Screen Of The Day is Small Cap Leaders, highly rated companies with a market capitalization of $300 million to $2... (full story)
KineMed extends ongoing diabetes collaboration with Pfizer
M2 - Thu Jun 05, 6:25AM CDT
Health technology company KineMed said on Wednesday that it has renewed its non-exclusive research collaboration for the advancement of novel approaches in metabolic disease, including Type II diabetes with Pfizer (NYSE FE). (full story)
Study Results, Updated Organization Structures, Appointments, and Technical Updates - Analyst Notes on Johnson & Johnson, Pfizer, Teva, Express Scripts and Idenix Pharmaceuticals
PR Newswire - Thu Jun 05, 5:10AM CDT
Today, Analysts Review released its analysts' notes regarding Johnson & Johnson (NYSE: JNJ), Pfizer Inc. (NYSE: PFE), Teva Pharmaceutical Industries Limited (NYSE: TEVA), Express Scripts Inc. (NASDAQ: ESRX) and Idenix Pharmaceuticals Inc. (NASDAQ: IDIX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3405-100free. (full story)
GlaxoSmithKline agrees to $105 million settlement
AP - Wed Jun 04, 5:39PM CDT
SAN DIEGO (AP) — GlaxoSmithKline PLC will pay $105 million to dozens of states to settle allegations that it unlawfully marketed its asthma drug Advair and the antidepressants Paxil and Wellbutrin. (full story)
Overall Average: 56% Sell
Recent stock forum discussions about PFE http://investorshangout.com/search?q=PFE&...mp;yt0=Go!
As Dividend Stocks Go, Philip Morris Is Expensive: Here Is a Cheaper Pick
Rupert Hargreaves, The Motley Fool - Motley Fool - Sat Jun 07, 9:00AM CDT
Every portfolio should have a dividend stock at its core to provide a degree of diversification and stability. The best dividend stocks are usually found within the consumer goods sector as the sector's defensive nature means that cash flows are... (full story)
Most active New York Stock Exchange-traded stocks
AP - Fri Jun 06, 5:13PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading: (full story)
Final Glance: Pharmaceuticals companies
AP - Fri Jun 06, 5:13PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading: (full story)
Pfizer Set to Possibly Rebound After Yesterday's Selloff of 1.14%
Comtex SmarTrend(R) - Fri Jun 06, 4:20PM CDT
Pfizer (NYSE
FE) traded in a range yesterday that spanned from a low of $29.34 to a high of $29.87. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $29.48 on volume of 26.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. (full story) The Dow Sets Another Record, But Why Are Pharma Stocks Falling?
Dan Caplinger, The Motley Fool - Motley Fool - Fri Jun 06, 3:30PM CDT
The Dow Jones Industrials set another all-time high on Friday, rising nearly 88 points and marking the eighth time the index has hit unprecedented levels this year. The catalyst for today's spike was the May employment report from the Labor... (full story)
Pfizer Falls, but the Dow's Record Run Continues
Dan Carroll, The Motley Fool - Motley Fool - Fri Jun 06, 1:38PM CDT
Stocks this afternoon as continuing the record run that has the Dow Jones Industrial Average touching a series of new highs. As of 2:30 p.m. EDT, the Dow had gained more than 78 points and sat just 85 points shy of the 17,000 mark. Most... (full story)
Midday Glance: Pharmaceuticals companies
AP - Fri Jun 06, 12:22PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.: (full story)
Early Glance: Pharmaceuticals companies
AP - Fri Jun 06, 10:46AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.: (full story)
5 Toxic Big Pharma Stocks You Need to Sell This Summer
at The Street - Fri Jun 06, 10:33AM CDT
As the summer fast approaches, pharma and medical device stocks are starting to show some nasty side effects. (full story)
Genomic Health Up on Fresh Cancer Study Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 05, 1:50PM CDT
Genomic Health's (GHDX) shares were up around 3.4% in the trading session following the news release. (full story)
Lannett Tops Trio Of Medical Small Cap Leaders
at Investor's Business Daily - Thu Jun 05, 7:02AM CDT
Small, fast-growing companies in hot industries, such as generics drugmaker Lannett, are good prospects for a stock watch list. Today's Screen Of The Day is Small Cap Leaders, highly rated companies with a market capitalization of $300 million to $2... (full story)
KineMed extends ongoing diabetes collaboration with Pfizer
M2 - Thu Jun 05, 6:25AM CDT
Health technology company KineMed said on Wednesday that it has renewed its non-exclusive research collaboration for the advancement of novel approaches in metabolic disease, including Type II diabetes with Pfizer (NYSE
FE). (full story) Study Results, Updated Organization Structures, Appointments, and Technical Updates - Analyst Notes on Johnson & Johnson, Pfizer, Teva, Express Scripts and Idenix Pharmaceuticals
PR Newswire - Thu Jun 05, 5:10AM CDT
Today, Analysts Review released its analysts' notes regarding Johnson & Johnson (NYSE: JNJ), Pfizer Inc. (NYSE: PFE), Teva Pharmaceutical Industries Limited (NYSE: TEVA), Express Scripts Inc. (NASDAQ: ESRX) and Idenix Pharmaceuticals Inc. (NASDAQ: IDIX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3405-100free. (full story)
GlaxoSmithKline agrees to $105 million settlement
AP - Wed Jun 04, 5:39PM CDT
SAN DIEGO (AP) — GlaxoSmithKline PLC will pay $105 million to dozens of states to settle allegations that it unlawfully marketed its asthma drug Advair and the antidepressants Paxil and Wellbutrin. (full story)
